시장보고서
상품코드
1769699

세계의 옥시코돈 염산염 시장 보고서(2025년)

Oxycodone Hydrochloride Global Market Report 2025

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 175 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

옥시코돈 염산염 시장 규모는 향후 수 년간 꾸준히 성장할 것으로 예상됩니다. 이러한 미래 성장의 예상되는 원동력으로는 만성 통증 사례의 지속적인 증가, 수술 후 중재의 상승 추세, 더 광범위한 암 진단, 노인 인구의 지속적인 성장, 정형외과 합병증의 더 큰 발생 등이 있습니다. 예측 기간 중에 예상되는 선진 패키징의 동향에는 남용 억제 기술의 진보, 서방형 제제의 처방, 맞춤형 치료를 위한 약리 유전학의 통합, 변조 방지 포장의 혁신, 방출 제어형 약물전달 시스템의 개량 등이 포함됩니다.

만성 통증의 유병률의 상승은 옥시코돈 염산염 시장의 성장을 가속할 것으로 예측됩니다. 이러한 유병률 증가는 주로 비만율 증가에 기인하며, 과도한 체중이 관절과 근육에 추가적인 압력을 가하여 골관절염과 요통과 같은 질환으로 이어지기 때문입니다. Office for Health Improvement and Disparities는 16세 이상의 개인 17.6%가 2022년에는 관절염과 지속적인 등과 관절 문제 등 장기적인 근골격계의 상태에 있으며, 2021년 17.0%에서 증가하고 있다고 보고했습니다.

옥시코돈 염산염 시장의 주요 기업은 오피오이드 의존의 위험을 줄이면서 통증 관리를 개선하기 위해 병용 요법을 포함한 선진 제품의 개발에 주력하고 있습니다. 위의 약제를 병용하는 것으로, 치료 효과를 높이거나, 복수의 작용기전을 타겟으로 하거나, 내성 리스크를 저하시키거나 하는 것입니다. 예를 들면, 2025년 4월, 미국의 제약회사 Elite Pharmaceuticals Inc.는 페르코셋 제네릭 의약품(옥시코돈 하이드로 클로라이드 및 아세트 아미노펜 정제, USP CII)를 출시했습니다. 이 제품은 3 개의 강도 -mg/325mg, 10mg/325mg, 325mg 정제가 있으며 중등도에서 중등도의 통증을 완화하는 데 사용됩니다. 진통효과가 있는 옥시코돈에 진통효과를 높이는 아세트아미노펜을 배합한 것입니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

  • 세계의 옥시코돈 염산염 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
  • 최종 이용 산업의 분석
  • 세계의 옥시코돈 염산염 시장 : 성장률 분석
  • 세계의 옥시코돈 염산염 시장 실적 : 규모와 성장, 2019-2024
  • 세계의 옥시코돈 염산염 시장 예측 : 규모와 성장, 2024-2029, 2034F
  • 세계의 옥시코돈 염산염 : 전체 시장 규모(TAM)

제6장 시장 세분화

  • 세계의 옥시코돈 염산염 시장 : 제품별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
  • 서방정
  • 즉방정
  • 경구용액
  • 서방형 캡슐
  • 세계의 옥시코돈 염산염 시장 : 투여 경로별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
  • 오랄
  • 보호자
  • 세계의 옥시코돈 염산염 시장 : 용도별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
  • 통증 관리
  • 수술 후 통증
  • 암 관련 통증
  • 세계의 옥시코돈 염산염 시장 : 유통 채널별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
  • 병원 약국
  • 소매 약국
  • 온라인 약국
  • 세계의 옥시코돈 염산염 시장 : 최종 사용자별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
  • 병원
  • 클리닉
  • 홈케어
  • 세계의 옥시코돈 염산염 시장 : 서방정유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
  • 남용 억제 제제
  • 남용 억제 효과가 없는 제제
  • 세계의 옥시코돈 염산염 시장 : 즉방정유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
  • 조합 제품
  • 단제제제
  • 세계의 옥시코돈 염산염 시장 : 경구액별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
  • 농축 용액
  • 표준 솔루션
  • 세계의 옥시코돈 염산염 시장 : 서방형 캡슐유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
  • 변조 방지 캡슐
  • 제네릭 의약품

제7장 지역별/국가별 분석

  • 세계의 옥시코돈 염산염 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
  • 세계의 옥시코돈 염산염 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

  • 옥시코돈 염산염 시장 : 경쟁 구도
  • 옥시코돈 염산염 시장 : 기업 프로파일
    • Viatris Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
    • Teva Pharmaceutical Industries Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석
    • Daiichi Sankyo Company Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석
    • Sun Pharmaceutical Industries Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석
    • Endo Pharmaceuticals Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석

제31장 기타 주요 기업 및 혁신 기업

  • Lupin Ltd
  • Mallinckrodt Pharmaceuticals Inc.
  • Euroapi SA
  • Ani Pharmaceuticals Inc.
  • Purdue Pharma LLP
  • Chattem Chemicals Inc.
  • Mayne Pharma Group Limited
  • Alvogen Inc.
  • Veranova
  • Temad Co.
  • Camber Pharmaceuticals
  • Noramco Inc.
  • Saneca Pharma AS
  • Rhodes Pharmaceuticals
  • Arevipharma GmbH

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

  • 옥시코돈 염산염 시장 2029 : 새로운 기회를 제공하는 국가
  • 옥시코돈 염산염 시장 2029 : 새로운 기회를 제공하는 부문
  • 옥시코돈 염산염 시장 2029 : 성장 전략
    • 시장 동향에 기초한 전략
    • 경쟁 전략

제36장 부록

SHW 25.07.18

Oxycodone hydrochloride is a potent opioid analgesic used to relieve moderate to severe pain. It works by binding to opioid receptors in the brain and spinal cord to reduce the perception of pain. It is frequently prescribed for managing pain following surgery or injury and for long-term conditions that involve chronic pain.

The primary forms of oxycodone hydrochloride include extended-release tablets, immediate-release tablets, oral solutions, and extended-release capsules. Extended-release tablets are formulated to gradually release the drug over an extended period, ensuring consistent therapeutic levels and minimizing the need for frequent dosing. This medication can be administered orally or through parenteral routes and is widely used to treat various types of pain, such as pain resulting from surgery or cancer. It is distributed through several channels, including hospital pharmacies, retail pharmacies, and online pharmacies, and is utilized across various settings such as hospitals, clinics, and home care environments.

The oxycodone hydrochloride market research report is one of a series of new reports from The Business Research Company that provides oxycodone hydrochloride market statistics, including the oxycodone hydrochloride industry's global market size, regional shares, competitors with the oxycodone hydrochloride market share, detailed oxycodone hydrochloride market segments, market trends and opportunities, and any further data you may need to thrive in the oxycodone hydrochloride market. This oxycodone hydrochloride market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The oxycodone hydrochloride market size has grown steadily in recent years. It will grow from $4.15 billion in 2024 to $4.32 billion in 2025 at a compound annual growth rate (CAGR) of 4.0%. The historical growth was influenced by an increasing prevalence of chronic pain conditions, a higher volume of surgical procedures, a surge in cancer diagnoses, an expanding aging population, and the escalating incidence of orthopedic ailments.

The oxycodone hydrochloride market size is expected to see steady growth in the next few years. It will grow to $5.01 billion in 2029 at a compound annual growth rate (CAGR) of 3.7%. Anticipated drivers of this future growth include the persistent rise in chronic pain cases, an uptrend in post-surgical interventions, more widespread cancer diagnoses, continued growth in the elderly demographic, and a greater occurrence of orthopedic complications. Prominent trends expected during the forecast period encompass the advancement of abuse-deterrent technologies, formulation of extended-release options, integration of pharmacogenomics for personalized treatment, tamper-resistant packaging innovations, and improvements in controlled-release drug delivery systems.

The rising prevalence of chronic pain is anticipated to drive the growth of the oxycodone hydrochloride market. Chronic pain is defined as pain that persists for more than three months and continues beyond the typical healing time of an injury or illness. This growing prevalence is mainly due to increasing rates of obesity, as excess body weight places additional pressure on joints and muscles, leading to conditions such as osteoarthritis and lower back pain. Oxycodone hydrochloride supports chronic pain management by delivering effective relief from moderate to severe pain, improving patient comfort and overall quality of life by targeting pain receptors in the nervous system. For example, in March 2023, the Office for Health Improvement and Disparities, a UK government department, reported that 17.6% of individuals aged 16 and over had a long-term musculoskeletal condition such as arthritis or persistent back or joint problems in 2022, up from 17.0% in 2021. This trend underscores how the increasing prevalence of chronic pain is contributing to the market growth of oxycodone hydrochloride.

Key players in the oxycodone hydrochloride market are concentrating on the development of advanced products, including combination therapies, to improve pain management while mitigating the risk of opioid dependency. Combination therapies involve using two or more medications together to boost treatment effectiveness, target multiple mechanisms of action, or lower the risk of resistance. For instance, in April 2025, Elite Pharmaceuticals Inc., a US-based pharmaceutical firm, launched a generic version of Percocet (oxycodone hydrochloride and acetaminophen tablets, USP CII). This product is available in three strengths-mg/325 mg, 10 mg/325 mg, and 325 mg tablets-and is used to relieve moderate to moderately severe pain. The formulation combines oxycodone for strong pain relief with acetaminophen to enhance analgesic efficacy. As a Schedule II controlled substance, it has a high potential for abuse and dependence and thus requires strict medical oversight.

In June 2024, Elite Pharmaceuticals Inc., a US-based pharmaceutical company, entered a partnership with Nostrum Laboratories Inc. to acquire three approved abbreviated new drug applications (ANDAs) for generic versions of Norco, Percocet, and Dolophine. This collaboration seeks to broaden their range of generic opioid analgesics, strengthen their presence in pain management, and provide patients with more affordable alternatives to branded pain relief medications. Nostrum Laboratories Inc. is a US-based company that manufactures prescription medications, including an oral solution that combines oxycodone hydrochloride and acetaminophen.

Major players in the oxycodone hydrochloride market are Viatris Inc., Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Ltd., Sun Pharmaceutical Industries Ltd., Endo Pharmaceuticals Inc., Lupin Ltd, Mallinckrodt Pharmaceuticals Inc., Euroapi SA, Ani Pharmaceuticals Inc., Purdue Pharma LLP, Chattem Chemicals Inc., Mayne Pharma Group Limited, Alvogen Inc., Veranova, Temad Co., Camber Pharmaceuticals, Noramco Inc., Saneca Pharma A.S., Rhodes Pharmaceuticals, and Arevipharma GmbH.

North America was the largest region in the oxycodone hydrochloride market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in oxycodone hydrochloride report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the oxycodone hydrochloride market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The oxycodone hydrochloride market consists of sales of oxycodone injectable formulations, oxycodone nasal sprays, oxycodone suppositories, and percocet. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Oxycodone Hydrochloride Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on oxycodone hydrochloride market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for oxycodone hydrochloride ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The oxycodone hydrochloride market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Extended Release Tablets; Immediate Release Tablets; Oral Solutions; Extended Release Capsules
  • 2) By Route Of Administration: Oral; Parental
  • 3) By Application: Pain Management; Post Surgical Pain; Cancer Related Pain
  • 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
  • 5) By End User: Hospitals; Clinics; Homecare
  • Subsegments:
  • 1) By Extended Release Tablets: Abuse-Deterrent Formulations; Non-Abuse-Deterrent Formulations
  • 2) By Immediate Release Tablets: Combination Products; Single-Agent Formulations
  • 3) By Oral Solutions: Concentrated Solutions; Standard Solutions
  • 4) By Extended Release Capsules: Tamper-Resistant Capsules; Generic Formulations
  • Companies Mentioned: Viatris Inc.; Teva Pharmaceutical Industries Ltd.; Daiichi Sankyo Company Ltd.; Sun Pharmaceutical Industries Ltd.; Endo Pharmaceuticals Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Oxycodone Hydrochloride Market Characteristics

3. Oxycodone Hydrochloride Market Trends And Strategies

4. Oxycodone Hydrochloride Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Oxycodone Hydrochloride Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Oxycodone Hydrochloride PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Oxycodone Hydrochloride Market Growth Rate Analysis
  • 5.4. Global Oxycodone Hydrochloride Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Oxycodone Hydrochloride Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Oxycodone Hydrochloride Total Addressable Market (TAM)

6. Oxycodone Hydrochloride Market Segmentation

  • 6.1. Global Oxycodone Hydrochloride Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Extended Release Tablets
  • Immediate Release Tablets
  • Oral Solutions
  • Extended Release Capsules
  • 6.2. Global Oxycodone Hydrochloride Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral
  • Parental
  • 6.3. Global Oxycodone Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pain Management
  • Post Surgical Pain
  • Cancer Related Pain
  • 6.4. Global Oxycodone Hydrochloride Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • 6.5. Global Oxycodone Hydrochloride Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Homecare
  • 6.6. Global Oxycodone Hydrochloride Market, Sub-Segmentation Of Extended Release Tablets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Abuse-Deterrent Formulations
  • Non-Abuse-Deterrent Formulations
  • 6.7. Global Oxycodone Hydrochloride Market, Sub-Segmentation Of Immediate Release Tablets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Combination Products
  • Single-Agent Formulations
  • 6.8. Global Oxycodone Hydrochloride Market, Sub-Segmentation Of Oral Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Concentrated Solutions
  • Standard Solutions
  • 6.9. Global Oxycodone Hydrochloride Market, Sub-Segmentation Of Extended Release Capsules, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tamper-Resistant Capsules
  • Generic Formulations

7. Oxycodone Hydrochloride Market Regional And Country Analysis

  • 7.1. Global Oxycodone Hydrochloride Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Oxycodone Hydrochloride Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Oxycodone Hydrochloride Market

  • 8.1. Asia-Pacific Oxycodone Hydrochloride Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Oxycodone Hydrochloride Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Oxycodone Hydrochloride Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Oxycodone Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Oxycodone Hydrochloride Market

  • 9.1. China Oxycodone Hydrochloride Market Overview
  • 9.2. China Oxycodone Hydrochloride Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Oxycodone Hydrochloride Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Oxycodone Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Oxycodone Hydrochloride Market

  • 10.1. India Oxycodone Hydrochloride Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Oxycodone Hydrochloride Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Oxycodone Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Oxycodone Hydrochloride Market

  • 11.1. Japan Oxycodone Hydrochloride Market Overview
  • 11.2. Japan Oxycodone Hydrochloride Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Oxycodone Hydrochloride Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Oxycodone Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Oxycodone Hydrochloride Market

  • 12.1. Australia Oxycodone Hydrochloride Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Oxycodone Hydrochloride Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Oxycodone Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Oxycodone Hydrochloride Market

  • 13.1. Indonesia Oxycodone Hydrochloride Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Oxycodone Hydrochloride Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Oxycodone Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Oxycodone Hydrochloride Market

  • 14.1. South Korea Oxycodone Hydrochloride Market Overview
  • 14.2. South Korea Oxycodone Hydrochloride Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Oxycodone Hydrochloride Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Oxycodone Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Oxycodone Hydrochloride Market

  • 15.1. Western Europe Oxycodone Hydrochloride Market Overview
  • 15.2. Western Europe Oxycodone Hydrochloride Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Oxycodone Hydrochloride Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Oxycodone Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Oxycodone Hydrochloride Market

  • 16.1. UK Oxycodone Hydrochloride Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Oxycodone Hydrochloride Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Oxycodone Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Oxycodone Hydrochloride Market

  • 17.1. Germany Oxycodone Hydrochloride Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Oxycodone Hydrochloride Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Oxycodone Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Oxycodone Hydrochloride Market

  • 18.1. France Oxycodone Hydrochloride Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Oxycodone Hydrochloride Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Oxycodone Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Oxycodone Hydrochloride Market

  • 19.1. Italy Oxycodone Hydrochloride Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Oxycodone Hydrochloride Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Oxycodone Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Oxycodone Hydrochloride Market

  • 20.1. Spain Oxycodone Hydrochloride Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Oxycodone Hydrochloride Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Oxycodone Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Oxycodone Hydrochloride Market

  • 21.1. Eastern Europe Oxycodone Hydrochloride Market Overview
  • 21.2. Eastern Europe Oxycodone Hydrochloride Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Oxycodone Hydrochloride Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Oxycodone Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Oxycodone Hydrochloride Market

  • 22.1. Russia Oxycodone Hydrochloride Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Oxycodone Hydrochloride Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Oxycodone Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Oxycodone Hydrochloride Market

  • 23.1. North America Oxycodone Hydrochloride Market Overview
  • 23.2. North America Oxycodone Hydrochloride Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Oxycodone Hydrochloride Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Oxycodone Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Oxycodone Hydrochloride Market

  • 24.1. USA Oxycodone Hydrochloride Market Overview
  • 24.2. USA Oxycodone Hydrochloride Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Oxycodone Hydrochloride Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Oxycodone Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Oxycodone Hydrochloride Market

  • 25.1. Canada Oxycodone Hydrochloride Market Overview
  • 25.2. Canada Oxycodone Hydrochloride Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Oxycodone Hydrochloride Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Oxycodone Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Oxycodone Hydrochloride Market

  • 26.1. South America Oxycodone Hydrochloride Market Overview
  • 26.2. South America Oxycodone Hydrochloride Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Oxycodone Hydrochloride Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Oxycodone Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Oxycodone Hydrochloride Market

  • 27.1. Brazil Oxycodone Hydrochloride Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Oxycodone Hydrochloride Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Oxycodone Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Oxycodone Hydrochloride Market

  • 28.1. Middle East Oxycodone Hydrochloride Market Overview
  • 28.2. Middle East Oxycodone Hydrochloride Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Oxycodone Hydrochloride Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Oxycodone Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Oxycodone Hydrochloride Market

  • 29.1. Africa Oxycodone Hydrochloride Market Overview
  • 29.2. Africa Oxycodone Hydrochloride Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Oxycodone Hydrochloride Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Oxycodone Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Oxycodone Hydrochloride Market Competitive Landscape And Company Profiles

  • 30.1. Oxycodone Hydrochloride Market Competitive Landscape
  • 30.2. Oxycodone Hydrochloride Market Company Profiles
    • 30.2.1. Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Daiichi Sankyo Company Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Sun Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Endo Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Oxycodone Hydrochloride Market Other Major And Innovative Companies

  • 31.1. Lupin Ltd
  • 31.2. Mallinckrodt Pharmaceuticals Inc.
  • 31.3. Euroapi SA
  • 31.4. Ani Pharmaceuticals Inc.
  • 31.5. Purdue Pharma LLP
  • 31.6. Chattem Chemicals Inc.
  • 31.7. Mayne Pharma Group Limited
  • 31.8. Alvogen Inc.
  • 31.9. Veranova
  • 31.10. Temad Co.
  • 31.11. Camber Pharmaceuticals
  • 31.12. Noramco Inc.
  • 31.13. Saneca Pharma A.S.
  • 31.14. Rhodes Pharmaceuticals
  • 31.15. Arevipharma GmbH

32. Global Oxycodone Hydrochloride Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Oxycodone Hydrochloride Market

34. Recent Developments In The Oxycodone Hydrochloride Market

35. Oxycodone Hydrochloride Market High Potential Countries, Segments and Strategies

  • 35.1 Oxycodone Hydrochloride Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Oxycodone Hydrochloride Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Oxycodone Hydrochloride Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제